rheumatology
Medicines

Emery’s top three

A drug to rival methotrexate, advances in T-cell biology and the cross-talk between the nervous system and the immune system were last year’s key highlights in RA research, according to past EULAR president Professor Paul Emery. In a year in review article for Nature Reviews Emery, a rheumatologist at Leeds Institute of Rheumatic and Musculoskeletal ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic